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1 Supplementary methods
Genomic DNA of K. pneumoniae was extracted using the Gentra Puregene kit (Qiagen, Hilden, Ger-
many). A genomic DNA library was prepared using Nextera DNA Sample Preparation Kit, tagged
using Nextera Index kit (Illumina, San Diego CA), and sequenced on a MiSeq sequencer (Illumina,
San Diego CA) following the manufacturer’s protocol. Paired-end 250 bp reads were filtered using
fastq-mcf [1], keeping reads with an average Phred quality score higher than 30 (Parameters: –max-ns
0 –mean-qual 30 -q 30). The genome was assembled using SPAdes version v3.9.0 with kmer sizes
ranging from 27 to 127, by steps of 4 [2]. Contigs were reordered based on the reference genome of K.
pneumoniae strain HS11286 (accession: NC 016845) using Mauve version 2015.02.13 [4]. Whole-genome
alignments were performed with nucmer [6]. The genome was annotated using Prokka version 1.11 [7].
Circos v0.69-4 was used to make a circular genome representations of the genome [5]. The presence
of plasmids was investigated using PlasmidFinder [3]. Antimicrobial resistance genes were identified
using ResFinder 2.1 [8].
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Table S1: Antibiotic susceptibility of K. pneumoniae FR-31.
Class Name Kirby-Bauer [mm] MIC Vitek [µg/ml] MIC Etest [µg/ml] Interpretation
Aminopenicillin / Amoxicillin / Clavulanic Acid 6 >=32 n/a R
inhibitor combination Ampicillin 6 >=32 n/a R
Ampicillin / Sulbactam n/a n/a >256 R
Beta-lactam/beta-lactamase inhibitor Piperacilllin / Tazobactam 6 >=128 n/a R
Ticarcillin / Clavulanic Acid n/a n/a >256 R
Cephalosporin II / Cefoxitin 6 >=64 n/a R
Cephamycin Cefuroxime n/a n/a >256 R
Cephalosporin III / IV Cefepime 6 >=64 n/a R
Cefpodoxime 6 >=8 n/a R
Ceftazidime 6 >=64 n/a R
Ceftriaxone 6 >=64 n/a R
Monobactam Aztreonam 6 n/a n/a R
Carbapenem Imipenem 13 8 4 R
Meropenem 6 >=16 16 R
Ertapenem 6 >=8 >32 R
Aminoglycoside Amikacin 22 <=2 n/a S
Gentamicin 6 n/a n/a R
Tobramycin 12 8 n/a R
Fluroquinolone Ciprofloxacin 6 >=4 n/a R
Levofloxacin n/a n/a >32 R
Moxifloxacin n/a n/a 8 R
Tetracyclines Tetracycline n/a n/a >256 R
Tigecycline n/a n/a 2 R
Miscellaneous Nitrofurantoin 10 128 n/a R
Trimethoprim / Sulfamethoxazole 6 >=320 n/a R
Rifampicin n/a n/a >32 R
Chloramphenicol n/a n/a >256 R
Fosfomycin n/a 64 96 R
Colistin n/a >=16 16 R
1 Disk diffusion and gradient tests were determined with cation-adjusted MH broth (Bio-Rad, Cressier, Switzerland). Disks and Etests were obtained from Oxoid, Thermofisher Scientific (Pratteln, Switzerland)
and bioMerieux (Marcy-l’Etoile, France) respectively. The minimum inhibitory concentration (MIC) values were determined using the AST-N242 card from VITEK2 (bioMerieux). For colistin, the MIC was
determined using UMIC (Biocentric, Bandol, France) according to the manufacturer’s instructions. EUCAST standards (version 2017) were used for categorical interpretation.
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